Shopping Cart
Remove All
Your shopping cart is currently empty
c-Met-IN-17 is a potent inhibitor of c-Met kinase with an IC50 of 0.031 μM, making it relevant for anticancer research. [1]
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | c-Met-IN-17 is a potent inhibitor of c-Met kinase with an IC50 of 0.031 μM, making it relevant for anticancer research. [1] |
| In vitro | c-Met-IN-17 (compound 29) exhibited an IC50 value of 0.068 μM for inhibiting D1228V c-MET enzymatic activity, as assessed by the ADP-Glo assay [1]. |
| In vivo | c-Met-IN-17, administered intravenously at a dose of 0.5 mg/kg to Wistar rats, demonstrated excellent bioavailability over a 24-hour period [1]. Pharmacokinetic analysis in Wistar rats [1] revealed the following parameters: clearance (Cl) at 60 mL/min/kg, steady-state volume of distribution (Vss_obs) at 4.6 L/kg, and a bioavailability of 100%. |
| Molecular Weight | 374.37 |
| Formula | C21H15FN4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.